贝瑞基因拟控股设立壹元童康 开展新生儿及儿童基因病一体化检测服务

Core Viewpoint - Berry Genomics (000710.SZ) announced the establishment of a joint venture, Henan Yiyuan Tongkang Gene Technology Co., Ltd., with individual investor Li Wei, focusing on integrated genetic testing services for newborns and children in key regions like Henan [1] Group 1: Joint Venture Details - The joint venture will have a registered capital of 1 million yuan, with Berry and Kang contributing 600,000 yuan (60% ownership) and Li Wei contributing 400,000 yuan (40% ownership) [1] - The joint venture aims to collaborate closely with public medical institutions and clinical medical enterprises [1] Group 2: Funding and Operations - Initial funding will be allocated for rent and personnel costs, with products and services, including gene sequencing and AI intelligent services, sourced from Berry and Kang and its subsidiaries [1] - The joint venture plans to increase its registered capital to no less than 50 million yuan based on business progress and expectations [1]